NCT05116488 is a clinical trial of ECG(electrocardigraph) in Brugada ECG Patterns, sponsored by Assiut University.

Who is sponsoring NCT05116488?

NCT05116488 is sponsored by Assiut University.

What drugs are being tested in NCT05116488?

Interventions in NCT05116488: ECG(electrocardigraph).

What condition does NCT05116488 study?

NCT05116488 studies Brugada ECG Patterns.

Is NCT05116488 still recruiting?

NCT05116488 is currently status unknown. Last updated 17 November 2021.

Last reviewed 2021-11-17 · How we verify

NCT05116488

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Detection of Electrocardiographic Brugada Patterns Using High Precordial Leads

Status unknown Last updated 17 November 2021

What this trial tests

trial testing ECG(electrocardigraph) in Brugada ECG Patterns in 300 participants. Status unknown.

Timeline

31 December 2021

Primary endpoint
31 December 2022

31 December 2023

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	31 December 2021
Primary completion	31 December 2022
Estimated completion	31 December 2023

Drugs / interventions tested

ECG(electrocardigraph)

Conditions studied

Brugada ECG Patterns — all drugs for Brugada ECG Patterns →

Sponsor

Assiut University

Who can join

Adults 18 to 80, any sex, with Brugada ECG Patterns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Detection of prevalence of Brugada patterns in our locality in asymptomatic patients , by standard 12 lead ECG level and high precordial ECG level, measuring how much the high precordial leads is more sensitive in Brugada patterns detection than standard level 12 lead ECG in our upper Egyptian population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Yield of regular practice of high precordial leads electrocardiogram among asymptomatic upper Egyptian population considering Brugada patterns, a cross-sectional study.
Ali AR, Abdelsabour M, Atta S. · · 2026 · PMID 41524999 · DOI 10.1186/s43044-026-00714-x

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05116488 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 17 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05116488.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing